Buyukkaya, E. Et Al. 2013. Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. AMERICAN JOURNAL OF CARDIOLOGY , vol.112, no.2 , 187-193.

Buyukkaya, E., Poyraz, F., Karakas, M. F., Kurt, M., Akcay, A. B., AKPINAR, I., ... Motor, S.(2013). Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. AMERICAN JOURNAL OF CARDIOLOGY , vol.112, no.2, 187-193.

Buyukkaya, Eyup Et Al. "Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention," AMERICAN JOURNAL OF CARDIOLOGY , vol.112, no.2, 187-193, 2013

Buyukkaya, Eyup Et Al. "Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention." AMERICAN JOURNAL OF CARDIOLOGY , vol.112, no.2, pp.187-193, 2013

Buyukkaya, E. Et Al. (2013) . "Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention." AMERICAN JOURNAL OF CARDIOLOGY , vol.112, no.2, pp.187-193.

@article{article, author={Eyup Buyukkaya Et Al. }, title={Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention}, journal={AMERICAN JOURNAL OF CARDIOLOGY}, year=2013, pages={187-193} }